US 9,811,635 B2
Immune and oxygen system measuring and drug screening method and apparatus
Samir Sofer, Clifton, NJ (US)
Filed by Samir Sofer, Clifton, NJ (US)
Filed on Aug. 14, 2015, as Appl. No. 14/826,619.
Application 14/826,619 is a division of application No. 13/695,150, granted, now 9,140,712, previously published as PCT/US2011/034051, filed on Apr. 27, 2011.
Claims priority of provisional application 61/328,409, filed on Apr. 27, 2010.
Prior Publication US 2015/0356266 A1, Dec. 10, 2015
This patent is subject to a terminal disclaimer.
Int. Cl. G06F 19/00 (2011.01); A61B 5/145 (2006.01); A61K 35/14 (2015.01); A61K 33/00 (2006.01); A61K 33/22 (2006.01); A61K 31/60 (2006.01); G01N 33/84 (2006.01); A61B 5/1455 (2006.01); G01N 33/48 (2006.01)
CPC G06F 19/3431 (2013.01) [A61K 31/60 (2013.01); A61K 33/00 (2013.01); A61K 33/22 (2013.01); A61K 35/14 (2013.01); G01N 33/84 (2013.01); A61B 5/145 (2013.01); A61B 5/1455 (2013.01); G01N 33/48 (2013.01)] 28 Claims
OG exemplary drawing
 
1. A method for enhancing an individual's immune system, said method comprising the steps of:
(a) providing an apparatus, including
(i) a first sensor that is an optical probe,
(ii) a second sensor that is a membrane probe, and
(iii) a reader processor in electrical connection with and responsive to said first and second sensors, wherein said first and second sensors detect molecular oxygen and nitric oxide and send electrical signals in response to the detection of said molecular oxygen and said nitric oxide to said reader processor, said reader processor reading said electrical signals and recording data related to said electrical signals as a function of time, including as part of said data concentrations of molecular oxygen and nitric oxide, changes in said concentrations, and rates of change in said concentrations;
(b) obtaining a sample of blood from the body of an individual, said sample including molecular oxygen and nitric oxide;
(c) measuring with said apparatus an initial concentration of said molecular oxygen and said nitric oxide to determine a baseline value for said individual;
(d) continuing measurement of the concentration of said molecular oxygen and said nitric oxide over time by said apparatus;
(e) stressing said sample;
(f) acquiring a first set of data from said sample by said apparatus over the course of a first interval of time following said stressing step to determine a first value for said molecular oxygen and a first value for said nitric oxide, said first value being a decrease in concentration of said molecular oxygen or a decrease in concentration of said nitric oxide with respect to said baseline;
(g) repeating said stressing step;
(h) acquiring a second set of data from said sample by said apparatus over the course of a second interval of time following said repeating step to determine a second value for said molecular oxygen and said nitric oxide, said second value being any increase in concentration of said molecular oxygen or any increase in concentration of said nitric oxide with respect to said first value;
(i) comparing by said apparatus said first and second values to preselected standard values to show the immune system performance capabilities of said individual, wherein steps (c)-(i) are repeated until a sharp increase of said molecular oxygen or said nitric oxide is detected; and
(j) administering said blood to said individual following step (i) to enhance said immune system performance capabilities.